Your browser doesn't support javascript.
loading
Investigating sirukumab for rheumatoid arthritis: 2-year results from the phase III SIRROUND-D study.
Thorne, Carter; Takeuchi, Tsutomu; Karpouzas, George Athanasios; Sheng, Shihong; Kurrasch, Regina; Fei, Kaiyin; Hsu, Benjamin.
Affiliation
  • Thorne C; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Takeuchi T; University of Toronto and Southlake Regional Health Centre, Newmarket, Ontario, Canada.
  • Karpouzas GA; Division of Rheumatology, Keio University School of Medicine, Tokyo, Japan.
  • Sheng S; Division of Rheumatology, Harbor-UCLA Medical Center, Torrance, California, USA.
  • Kurrasch R; GlaxoSmithKline, Collegeville, Pennsylvania, USA.
  • Fei K; Division of Rheumatology, Harbor-UCLA Medical Center, Torrance, California, USA.
  • Hsu B; Division of Rheumatology, Harbor-UCLA Medical Center, Torrance, California, USA.
RMD Open ; 4(2): e000731, 2018.
Article in En | MEDLINE | ID: mdl-30564449
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies Language: En Journal: RMD Open Year: 2018 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies Language: En Journal: RMD Open Year: 2018 Type: Article Affiliation country: United States